At present, the diagnosis of AD is made following criteria that rely on clinical, neuropsychological, instrumental (e.g., magnetic resonance imaging, fludeoxyglucose F 18 positron emission tomography—PET, amyloid PET, tau PET, and computed tomography) and laboratory tests [40]. Here, MAPT is linked to Alzheimer disease.